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ABSTRACT 
    Dopamine neurons of ventral tegmental area (VTA) are critical for control of homeostatic feeding, 
which relates to food intake necessary for maintaining normal physiological function. It also plays an 
important role in hedonic or ‘reward’ feeding. Alteration of mesolimbic dopamine pathways can change 
both baseline homeostatic and reward feeding. The melanocortin system of the hypothalamus also is 
important for control of feeding, and recently it has been shown that melanocortins can modulate the food 
intake by acting at dopamine pathways. Here, we tested whether injection of melanocortin receptor 
agonists into the VTA also affected reward feeding. Injection of melanocortin receptor agonists into the 
VTA decreased consumption of rewarding sucrose solutions (hedonic feeding), in addition to the 
expected reductions in normal chow intake (homeostatic feeding). These studies will give a better 
understanding of the mechanisms regulate acutely food intake and may have implication for treating 
obesity. 
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1. INTRODUCTION 
    Obesity has recently been designated as a disease by the American Medical Association in 
2013. It is a physical disease that may be induced by behavioral and genetic problems. In this 
modern society, the population of obesity is booming and it causes huge medical expenses. 
Obesity (defined as a BMI value is above 30 kg/m2 (the BMI above 25 kg/m2 is considered as 
overweight), or waist circumference is greater than 40 inches (male)) population is increasing 
during the past three decades, although the increasing rate of prevalence tend to be slight (U.S. 
adult obesity: 14.5%- 30.5% during 1976- 2000, around 35% in 2010 and no significant 
difference compare with 2003-2008), it still keeps 31.8% of U.S. children and 68.8% of U.S. 
adults in either obesity and overweight (the prevalence of obesity is 16.9% and 35% 
individually) (Flegal et al., 2012, Ogden et al., 2012). Obesity is not only a prevalent disease in 
U.S. but also around the world, both developed and developing countries have increased the 
budget for the treatment of various illnesses, such as diabetes, cardiovascular diseases and 
certain types of cancer that are higher risk of diseases associated with obesity. It is not an issue 
for people to obtain food in most countries today but finding the balance between energy 
consumption and expenditure has become a major challenge and burden for our current and 
future generations. The control of homeostatic and reward feeding is critical in regulation of 
body weight and food intake, but it is still not clear in which factors or mechanisms to maintain 
energy homeostasis of body or cause the obesity. Individuals “need” to eat in order to maintain 
energy requirements for normal function, thus the need-based eating is the homeostatic feeding 
which helps keep the energy homeostasis of the body. Additionally, people would “like or want” 
to finish the appetizing plate even in satiety due to the pleasure effect of eating. Hedonic, the 
want-based feeding makes people tracing the reward and it may be the reason to cause the 
overweight. 
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1.1. Homeostatic Control in Brain Circuit 
    The body weight is regulated by that the central nervous system by its control of food intake, 
locomotion and metabolism, however, the interaction among the different parts of the nervous 
system to control these factors is still unclear. Homeostasic feeding is regulated by different parts 
of brain besides the peripheral factors such as the concentration of glucose in blood or some 
hormones such as CCK, ghrelin, leptin and insulin that are secreted by digestive system or 
adipose tissue.  
    Through controlling feeding and body weight, the ARC (hypothalamic arcuate nucleus), VMH 
(ventromedial hypothalamus), VLH (ventrolateral hypothalamus) and brainstem had been 
considered centers of homeostatic feeding (DeFalco et al., 2001). The subjects with bilateral 
lesions of VMH and VLH result in opposite effects, hyperphagia (which cause obesity at later) 
and aphagia (which lead to death by starvation without awareness), suggested VMH and VLH 
are responsible to satiety and hunger respectively (Harrell et al., 1975, King and Frohman, 1985, 
Williams et al., 2000). More recent evidence indicates that other parts of the brain, such as the 
ARC are important for homeostatic feeding. There are two different sets of neuropeptides 
released by two distinct groups of neuron in ARC where integrates most of signals from 
periphery, controls appetite hormones and be regulated by positive and negative feedback 
(Schwartz et al., 2000). First, catabolic peptides, such as proopiomelanocortin (POMC)- a 
precursor of melanocyte stimulating hormone (MSH) corticotropin (ACTH), β-endorphin and 
encephalin released from POMC neurons in ARC when obtain leptin and insulin from adiposity 
or blood, can reduce the food intake and increase energy expenditure that would result the loss of 
body weight. Second, the anabolic neuropeptides, the AgRP and NPY are released when other 
part of ARC receiving signals from adiposity, have the effect of accumulation of body fat by 
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increasing food intake and reducing the energy expenditure.  The nucleus of solitary tract (NTS) 
of brainstem integrates the satiety signals such as CCK from digestive tract, sensory input from 
viscera and the catabolic or anabolic projection from paraventricular nucleus (PVN) or LH where 
are afferent through ARC, that may send either signals to periphery for regulating the food intake 
(Schwartz et al., 2000). Anatomically, it is clear that there are several major parts of CNS control 
homeostatic feeding. The hypothalamus, ARC and brainstem receive signals of food intake and 
adiposity from periphery and affect energy homeostasis via the autonomic nervous system, 
however, the mechanisms in control of eating are still not fully understood and need to be further 
investigated. 
1.2. Melanocortin in Homeostatic Feeding 
    Melanocortin system, includes distinct groups of neurons which release neuropeptides POMC 
and AgRP, is critical involving caloric homeostasis and relating to the changing of body weight 
by its catabolic and anabolic effects respectively. The melanocortin receptors in afferent neurons, 
regulates homeostatic feeding and body weight. Melanocyte stimulating hormones (MSH), such 
as α, β, and γ-melanotropin, are derived from proopiomelanocortin (POMC). MSH and its analog 
such as melanotan II (MTII) are anorexigenic agents that suppress the feeding behavior and 
agonizing melanocortin receptors (Klusa et al., 1999, Hamilton and Doods, 2002, Pierroz et al., 
2002). Previous study demonstrated that two hours following intracerebroventricular (ICV) 
injection with MTII, mice had significantly decreased food intake (Fan et al., 1997, Azzara et al., 
2002). Thus, the POMC neuron produced MSHs acts as an appetitive suppressor in brain that 
may alter feeding behavior through agonizing its receptors (Bertolini et al., 1986, Roselli-
Rehfuss et al., 1993, Millington, 2007). Furthermore, the administration of MSHs had been 
identified to not only modulate feeding behavior, but also is a useful treatment to improve 
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cardiovascular function  (Bertolini et al., 1986).  
    Another set of neuron, AgRP neuron, which projection to POMC neuron had proved able to 
regulate eating through melanocortin system. AgRP are endogenous antagonists/ inverse agonists 
of melanocortin receptors that are not only able to stop decrease food intake but also stimulate 
eating. With specifically stimulating to AgRP neurons in hypothalamic ARC by 
channelrhodopsin, the optogenic tools, mice exhibit profound eating (Aponte et al., 2011, 
Krashes et al., 2011, Atasoy et al., 2012, Cansell et al., 2012). The brainstem administration of 
SHU9119, an exogenous antagonist of melanocortin receptor, has same effect of feeding with 
AgRP (Grill et al., 1998). The control of satiety and hunger are supposed to involve with the 
feedback of melanocortin system that can be agonized and antagonized by various factors. 
Fasting rats have increased AgRP/ NPY neuron mRNA and decreased POMC neuron mRNA 
comparing with fed ad libitum rats (Korner et al., 2001). Korner and colleagues found 
hypothalamic leptin injections in rats was nearly completely reversal of the AgRP/ NPY and 
POMC neuron mRNAs expression when in fasting state.  
    There are 5 types of melanocortin receptor, type 1 through 5. The MC3R and MC4R are 
expressed in central nervous system and the functions to homeostatic feeding had been tested by 
using MSH, MTII, AgRP or SHU9119 in previous studies (Cone, 1999, Kishi et al., 2003, Cone, 
2005, 2006, Fani L, 2013). Melanocortin receptor is a g-protein coupled receptor which 
activation within cAMP/ PKA pathway not only stimulating feeding but also improving long 
term potentiation in hippocampus (Shen et al., 2013). Generally, MC3R is likely to control 
physiological metabolism, such as energy expenditure, oxygen consumption and locomotion. For 
MC4R, it plays a critical role in food intake and energy balance. In Butler and Cone’s review 
study, MC3RKO subjects exhibited increased adipose mass and decreased lean mass despite the 
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absence of hyperphagia when exposed to high fat diet; however, MC4RKO subjects were 
hyperphagic, had increased both lean and fat mass, hyperglycemia, hyperinsulinemia and 
hyperleptinemia, which resulted in type 2 diabetes. MC4RKO mice had higher energy intake 
during moderate fat chow was applying and had significant body weight increase. MC3R and 
MC4R alter appetite and metabolism independently in different way, the MTII administration to 
either MC3R or MC4R knockout mice indicates melanocortin receptors are required for 
regulating energy homeostasis by MSH (Butler et al., 2001, Butler and Cone, 2002). Previous 
study shows the overexpression of POMC neurons in ventral tegmental area (VTA) can 
significantly ameliorates the high-fat induced dietary obesity (Andino et al., 2011), suggested an 
important role about reward is also responsible to food intake and body weight due to the 
motivation may change the caloric consuption such as fat and sugar which is parallel to obesity. 
1.3. Dopamine and Hedonic Feeding 
    Although there are various studies and reviews discuss the anatomy of homeostatic pathway 
and its regulation in feeding behavior, the complete mechanisms to cause obesity are still unclear 
because there is another critical role, which makes further food intake when in satiety, the reward 
system. Food can also be a natural reward in certain brain circuits such as mesolimbic pathway. 
Some previous studies in several decades ago had shown the feeding, especially the acute 
feeding following starvation, could marked induced the dopamine turnover in several parts of 
brain such as hypothalamus, nucleus accumbens and amygdala (Heffner et al., 1980, Hernandez 
and Hoebel, 1988). Hedonic effect can be caused by high fat and appetizing sugar food that gives 
pleasure feeling to consumer as a reward through the brain circuit. Dopamine released in certain 
brain circuit such as mesolimbic pathway that plays a critical role of reward eating.  
    Food is a type of energy for homeostatic balance to maintain body weight and functions. 
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Palatable food, such as those high in fat and sugar has hedonic effect that arouse feeding 
behaviors by alerting specific brain circuits (Saper et al., 2002). Animals also experience failed 
reproduction, impaired immune system and have chronic stress when the food intake is short 
whereas the pleasurable rewarding is able to relieve the stress through mesolimbic pathway 
(Ulrich-Lai et al., 2010). Neurologists have found the behavior of obese animal model to be 
similar with drug addiction (Kenny, 2011). Previous studies demonstrated that addictive animals 
would work hard, such as lever press, nose poke or endure distress like electric foot shock for 
rewards such as drugs and food (McFarland et al., 2004). Food is a natural reward within brain 
that can cause motivation, reinforcement and addiction consequently. The potential problem is 
that reward effect may result in compulsion, reinforcement and addiction, however, the 
mechanism is still unclear (Berridge, 2004). The obese people have decreased density of D2 
receptors, which has the similar mechanism with the drug addicts (Wang et al 2001). 
    Dopamine as neurotransmitters are critical factors involve in reward system and give animals 
hedonic effect (Adamantidis et al., 2011). There are several pathways regulating reward system 
in brain. The mesocortical and mesolimbic dopamine pathway, which is made of dopamine 
neurons in VTA that project to frontal cortex, amygdala, hippocampus and nucleus accumbens, 
are reward circuits controlling hedonic effect (Wise, 2004, Britt et al., 2012). The nigrostriatal 
pathway which neurons project to caudate putamen from substantia nigra compacta is about the 
feeding motivation and also partially involved in the production of movement, as a part of basal 
ganglia motor system (Szczypka et al., 2001). Parkinson’s disease is characterized by apoptosis 
of dopamine neurons in the substantia nigra and cause lower body weight compare with healthy 
people (Beyer et al 1995). Patients that are given levodopa treatments, a dopamine precursor that 
can easily cross blood brain barrier, have significant weight loss suggesting the medication may 
	   7	  
be responsible and dopamine can be a important factor in regulation of body weight (Bachmann 
et al 2009). 
The food reward and reward- predictive stimuli can evoke phasic dopamine signaling 
throughout the striatum (Brown et al., 2011). Dopamine deficient mice do not only lose the 
preference of appetite, but also decrease regular food intake that cause decreased body weight 
and death during the experiment (Zhou and Palmiter, 1995, Palmiter, 2008), but reversed the 
hypophagia when nigrostriatal dopamine was restored (Hnasko et al., 2006). Dopamine in 
reward is a key factor that motivates subjects to alter their eating (Palmiter, 2007). The D2R 
knock-out mice also increases hypothalamic leptin sensitivity; thus, the injection of leptin into 
D2R knock-out mice will cause hypophagia and higher locomotion. The role of VTA has been 
well demonstrated in drug addiction, and the addictive mechanism can also be applied for natural 
food reward that makes human tend to accumulate more energy as body fat (Kelley and 
Berridge, 2002, Volkow and Wise, 2005, Sulzer, 2011).  
    Dopaminergic neurons arise from VTA in the mesocorticolimbic dopamine pathway were 
broadly discussed in reward, learning and memory, prediction and incentive salience (want-
based behavior)(Wise, 2004, Cacciapaglia et al., 2011). The projection from VTA is not only 
given reward but also the aversion via distinct groups of neuron (Zhang and Kelley, 1997, 
Lammel et al., 2012). Current study used optogenetic tools to investigate the role of VTA that 
plays different roles in both feeding and reward through different types of afferent neurons, such 
as glutamatergic afferent can activate dopamine neuron and stimulate the dopamine release in 
VTA whereas the GABAergic neuron has the opposite effect for controlling the reward and 
aversion. These finding give a possibility to change the appetizing by inducing different sets of 
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neurons (Geisler and Wise, 2008, Lammel et al., 2012, Srinivasan et al., 2012, Tan et al., 2012, 
van Zessen et al., 2012, Wittmann et al., 2013). 
1.4. Melanocortin Regulates Dopaminergic Neuron Related Feeding 
    The roles of mesolimbic dopaminergic and melanocortin systems in regulating feeding 
behavior are well known; however, whether melanocortin and dopamine neuron act together or 
independently to regulate food intake and reward has not been highly studied. Evidence shows 
not only the MC3R and MC4R are found in VTA (Butler and Cone, 2002) but also the 
administration of α- MSH into VTA causes increased dopamine level in NAc and stimulates 
grooming behavior which can be blocked by MC4R antagonists (Lindblom et al., 2001). In 
chronic stress, the activation of MC4R decreases the strength of excitatory synapses of D1R in 
NAc neurons (Lim et al., 2012). The POMC overexpression in ARC or VTA leads to TH 
(tyrosine hydroxylase) level increase in both area and tempered increasing body weight (Andino 
et al., 2011). Furthermore, Roseberry recently showed that administering MC3R and MC4R 
agonist and antagonist in VTA acutely and chronically affect food intake and body weight 
(Roseberry, 2013). This suggests melanocortin can act on dopamine pathway to regulate 
behaviors including homeostatic feeding.  This raises the question of whether the melanocortin 
system can also affect reward related food intake through dopamine system of the VTA. 
1.5. Hypothesis 
    In this study, we will test whether melanocortins act on dopamine neuron to regulate reward 
feeding by testing whether the activation of MC3R and MC4R in VTA affects intake of 
pleasurable and rewarding sucrose solutions. These studies will provide better understanding of 
mechanisms controlling food intake, especially appetizing foods. The results also could 
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contribute to identifying a novel tool for investigating the appetitive behavior and effective 
treatment to human obesity.  
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2. MATERIALS AND METHODS 
2.1. Animals 
    Young adult male Sprague–Dawley rats (Harlan Laboratories, Madison, WI, USA), weighing 
around 250 grams at the beginning of experiment, were used for all experiments. Rats receive 
one-week acclimation after delivery and after surgery. Rats were housed with ad libitum food 
and water under a 12 hour light-dark phase. All protocols and procedures were approved by the 
Institutional Animal Care and Use Committee at Georgia State University and conformed to the 
NIH Guide for the Care and Use of Laboratory Animals.  
2.2. Cannula Implantation 
For all experiments, indwelling cannulae were implanted bilaterally targeting the VTA.  Rats 
were anesthetized with isoflurane (1–5 %). Rats received implantation of stainless steel cannula 
(26 gauge) (Plastics One) at bilateral VTA (A/P −5.6, M/L +/ −2.2, and D/V −7 relative to 
bregma; angle of 12° to the midline) on a stereotactic apparatus (David Kopf Instruments, 
Tujunga, CA, USA) using standard flat-skull techniques. Cannulas were fixed by dental cement 
with anchoring to the skull using 4 stainless steel screws. Stainless steel wire stylets were placed 
in the cannula to prevent occlusion. The injectors extended 1 mm beyond the end of cannula. 
Rats were given ibuprofen (~15 mg/kg) in their drinking water for 3 days prior and post surgery 
for pain relief. 
2.3. Microinjection 
    Rats were gently restrained by hand for processing microinjection. Stainless steel injectors (33 
gauge) extending 1 mm beyond the tip of the cannula were inserted bilaterally. Injections done in 
volume of 0.2 µl were injected into VTA over 1 minute by using Hamilton syringes connected to 
microinfusion pump. Injectors were left in one additional minute after injection to limit backflow 
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up the cannula. Stylets were placed back to cannulas after removing injectors. Rats were 
immediately moved back to testing cages for testing. Injections were spaced a minimum of three 
days apart to allow for full recovery between injections. Rats received the mock injection prior to 
injection for acclimating to inject procedure. MTII was dissolved in sterile saline, which was 
used for all control injections. 
2.4. Two-Bottle Choice Test 
    For two-bottle choice test, rats were set in individual testing cages (acute tests) or in their 
home cages (prolonged access tests) with two bottles filled with water or sucrose solutions (1%, 
2% or 10%). During acute tests rats did not have access to food. Testing was done during the 
early light phase for the short-term 4 hour acute intake (1% or 10% sucrose solution) and at the 
onset of the dark phase for prolonged access, 24 hours long-term intake (2% sucrose). Bottle 
positions were switched on every trial to prevent habit. Rats were acclimated to test procedure 
until the intake of sucrose and water was stable prior to testing with injection of MTII. 
 
 
Figure 1. Diagram of two bottle choice test   
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2.5. Measurement of Food Intake  
    Rats were given access to normal chow (Purina rodent diet #5001, PMI Nutrition 
International) throughout all experiments, except during the short-term access 2 bottle choice 
tests, when no food was present. Food intake was measured by providing rats a set amount of 
food and then weighing the food at specific intervals (e.g. 24 hours).  Both food intake and 
sucrose solution in every trial were converted total caloric intake measured in each experiment 
using caloric values of 3.36 kcal/g for chow and 3.94 kcal/g for sucrose. 
2.6. Histology 
    For confirming the location of injection site, 0.2 µL Neurotrace, a fluorescence Nissl stain, 
was injected at the end of all experiments, 24 hours before perfusion. All rats were completely 
anesthetized with ketamine/ xylazine (93/7 mg/kg) and were transcardially perfused with cold 
saline and 4% paraformaldehyde. Brains were removed and post-fixed in 4% paraformaldehyde, 
at 4 °C overnight. Coronal brain slices (100 µm) containing the VTA were prepared by using 
vibrating blade microtome. The slices were mounted to glass slides and the location of injected 
Neurotrace was observed and captured the images by Nikon fluorescence microscope. Brain 
sections were then stained with cresyl violet, and the locations of the injectors were determined 
by light microscopy. The locations of all injection sites are indicated in diagrams of rat brain 
atlas (Paxinos and Watson, 1998) (Figure 2). 
2.7. Data Analysis and Statistics 
    All data are presented as means ± SEM. Data were plotted using Office Excel (2010 
Microsoft, Inc), and statistical analysis was performed using SigmaPlot (v12.0; Systat Software, 
Inc). All data were analyzed using repeated measures ANOVA as appropriate, followed by 
	   13	  
Tukey’s post hoc tests for individual comparisons. All analyses were performed with a 
significance level of p<0.05  set a priori. 
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3. RESULTS 
3.1. The Conformation of Injector Sites 
    The location of each injection site is indicated on the diagrams of rat brain atlas (Paxinos and 
Watson, 1998) shown in Figure 2. Sample images of injection site including Fluorescence Nissl 
stain are also shown in Figure 2. One rat was excluded due to the injection outside of VTA and 4 
rats’ injection sites could not be confirmed due to the death during experiments. 
Figure 2. The confirmation of injector site. A. Diagram of rat coronal sections 
demonstrating injector locations in VTA. The locations of the injectors are indicated by dots. 
Numbers next to each section indicate the location of the section relative to bregma (Paxinos 
and Watson 1998). B, C, D, Sample images (bregma -5.30) of the same brain section 
containing the injector locations. B and D show in bright field, C shows the injection of 
Neurotrace 
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3.2. Does VTA MTII Affect Intake of Low Concentration (2%) Sucrose Solution in Long-
Term Access Tests? 
    We previously show MTII injection to VTA could decrease food intake (reference). Here, we 
initially tested whether injection of MTII into the VTA also affected hedonic feeding by testing 
whether administration of MTII to the VTA reduced amount of sucrose intake in 2 bottle choice 
tests. As control, we also measured the food intake.      
    Following the MTII injection to bilateral VTA just prior to the onset of the dark cycle, there is 
significantly decreased 2% sucrose intake at 24th hours in dose-dependent manner of 50 pmol 
and 10 pmol but not 1 pmol, compared with the saline injection group (Figure 3). The MTII 
injection also caused decreased sucrose preference that was from ~80% of total solution 
consumption to ~65% without affecting the intake of water. In agreement with previous study 
(Roseberry, 2013), MTII also caused decreasing of both chow and total caloric intake in these 
tests (Figure 3).  
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Figure 3. MTII injection to VTA suppressed sucrose, food and total energy intake in 
prolonged access tests. A. 24 Hr sucrose intake in 2 bottle choice tests B. 24 Hour water 
intake in 2 bottle choice tests.  C-D. 24 Hour food intake (C) and total caloric intake (sucrose 
+ chow; D) after MTII injection to the VTA in the 2 bottle choice tests.  n=7.  **p<0.01 
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3.3. Does VTA MTII Affect Short-Term Intake of High Concentration (10%) Sucrose? 
    In order to understand the hedonic feeding, rats were given choice tests in satiety during the 
early light phase. MTII was injected to bilateral VTA and rats were given 2 bottle choice tests 
between water and 10% sucrose solution to test whether the melanocortin receptor agonist is 
sufficient for blocking acute intake of sucrose solution.  
    In the early light phase, MTII 50 pmol injection significantly blocked sucrose intake starting at 
second hour (Figure 4). Rats keep highly preference to 10% sucrose solution following all 
injections with relatively low water intake when comparing with 10% sucrose solution. In acute 
10% sucrose test, MTII also reduced the 24 hour food and caloric intake as expected but this was 
only observed for 50 pmol dose and with no effect for 10 pmol or less (Figure 4). 
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Figure 4. MTII injection to VTA suppressed acute intake of high concentration sucrose 
in 2 bottle choice tests. A-C Sucrose intake at 1 (A), 2 (B), and 4 (C) hours post-MTII 
injection in 2 bottle choice tests.  D-F. Water intake at 1 (D), 2 (E), and 4 (F) hours post-MTII 
injection in 2 bottle choice tests.  G-H.  24 hour intake of chow (G) and total calories (H) 
following MTII injection in the 2 bottle choice tests.  n=11, **p<0.01 
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3.4. Does VTA MTII Affect Short-Term Intake of Low Concentration (1%) Sucrose? 
    At last, we also test whether MTII acutely affect intake of a low concentration of sucrose 
solution that is only marginally preferred and test if MTII injection acutely change this 
consumption pattern during the early light phase. Water and 1% sucrose solution were given and 
measured at 1st, 2nd and 4th hour following the injection of saline or MTII.  
    The 1% sucrose drinking in early light phase was dose-dependently decreased by MTII 
injections at 1st, 2nd and 4th hours (Figure 5). The 50 pmol MTII injection to bilateral VTA had 
caused significantly decreased drinking of 1% sucrose since the second hour. 10 pmol MTII 
decreased sucrose intake but was not statistically significant (p=0.06). No significant difference 
was found in water drinking (Figure 5 d-f). MTII injection also decreased 24 hour food and 
caloric intake in these experiments as expected (Figure 5).  
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Figure 5. MTII injection to VTA suppressed acute intake of low concentration sucrose in 
2 bottle choice tests. A-C Sucrose intake at 1 (A), 2 (B), and 4 (C) hours post-MTII injection 
in 2 bottle choice tests.  D-F. Water intake at 1 (D), 2 (E), and 4 (F) hours post-MTII injection 
in 2 bottle choice tests.  G-H. 24 hour intake of chow (G) and total calories (H) following 
MTII injection in the 2 bottle choice tests.  n=9, **p<0.01 
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4. DISCUSSION 
    In this study, we test whether melanocortin system is critical to alter either homeostatic or 
reward eating by MTII agonizing central melanocortin receptors that express in part of 
mesolimbic dopamine pathway, the VTA. It is known that feeding can alter the dopamine level 
in mesolimbic pathway, in addition, we ask whether the animals consume appetizing sucrose 
solution in satiety and this reward-related feeding can be suppressed by melanocortins injection. 
Thus, in this study, the principle examination is to ask whether the injection of melanocortin 
receptor agonist to VTA affect the intake or preference of appetizing sucrose solutions and find 
the clue if melanocortins can affect hedonic feeding by directly inducing dopamine neuron. 
    In all of the experiments in this study, the 50 pmol dose of MTII to VTA was able to suppress 
both chow and total caloric intake in 24 hours, which demonstrate the suppression of 
homeostatic feeding, as we have observed before (my paper reference).  50 pmol MTII also 
decreased the sucrose intake in both chronic and acute tests that suggested MTII injection to 
VTA did change the hedonic feeding. Additionally, the result suggests long-lasting stability of 
MTII to alter feeding. 
    We found that the lower 10 pmol dose of MTII decreased the intake of food and total calories 
in 24 hours in 1% sucrose, but not 10% sucrose testing, although the suppression of 10 pmol 
MTII was not statistically significant. When comparing acutely high and low sucrose intake in 
lower MTII injection, it suppressed 24 hours food and total caloric intake in low sucrose tests but 
not in high sucrose, this suggests high concentration sucrose might stimulates more reward in 
mesolimbic pathway which result in subsequently higher food intake that lower dose MTII could 
not suppress. The 24 hours energy intake between both acute feedings, which shows about 10 
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Kcal difference in either lower dose MTII injections, gives a clue that different level of reward 
may be regulated by melanocortins in dose dependent manner. 
    At first, we conclude the MTII injection to bilateral VTA is able to alter homeostatic feeding, 
which decreases the total energy intake that consistent with the results of MC3R and MC4R 
knock-out study (Butler and Cone, 2002). The MTII injected rats had less consumption of food 
that indicates the mechanism via MC4R not MC3R, because MC4R regulate the food intake and 
MC3R likely control the physiological metabolism (Butler and Cone, 2002). The role of MC3R 
in this study may be needed to have test, such as the locomotion and the energy expenditure. In 
addition, we also suggest that melanocortins may have the effect to dopamine neurons in VTA to 
alter the feeding, especially the hedonic feeding. We already show the MTII injection to VTA 
suppress intake of appetizing sucrose when rats were in satiety and sucrose is also known as a 
highly reward to mesolimbic pathway, furthermore, melanocortin receptors had been found on 
D1R neurons (Cui and Lutter, 2013), thus, we likely believe that melanocortins can regulate 
hedonic feeding by directly or indirectly affect dopamine neurons in mesolimbic pathway.   
    In summary, through the administration of melanocortin receptor agonist into bilateral VTA, 
the study concludes that the hedonic feeding can be altered and the melanocortin receptor may be 
related to dopaminergic neuron, which had been proven to change the motivation of eating. 
Previous study demonstrated that i.c.v. injection of MTII to 3rd or 4th ventricle can decrease the 
meal size and glucose intake which comfirms the result of our study (Williams et al., 2002, De 
Jonghe et al., 2012). This specific injection to VTA with MTII helps us getting better 
understanding about the relation between homeostasis and motivation. It opens up the potential 
idea that more researches can be done to apply the finding on other parts of the brain circuit such 
as NAc and CPu in various addictions, such as ethanol and drugs (Szczypka et al., 2001, Zhang 
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and Kelley, 2002, Navarro et al., 2011, Lim et al., 2012). Although there are more mechanisms 
of homeostatic and hedonic pathways that need to be worked on, the finding of the effect from 
melanocotin receptor to mesolimbic DA pathway could be a useful start to treat obese people in 
the future.  
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